Administrative Core
行政核心
基本信息
- 批准号:10369068
- 负责人:
- 金额:$ 27.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-12-17 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:AccountingAdvisory CommitteesAgreementAntibodiesAntigensB-LymphocytesBudgetsCell LineageClinical TrialsCommunicationDataData AnalysesData ProvenanceDevelopmentEnsureExpenditureExperimental DesignsFerritinFundingGoalsGrantGuidelinesHIV-1HIV-1 vaccineHumanHuman ResourcesIACUCImmune responseInfrastructureInstitutesInstitutional PolicyLeadMeasuresMonitorNational Institute of Allergy and Infectious DiseaseOccupational activity of managing financesOutcomeParticipantPhase I Clinical TrialsPoliciesPractice GuidelinesPreparationProductionProteinsProtocols documentationPublicationsRegulationReportingResearchResearch PersonnelResourcesRightsRiskSiteSupervisionTestingTimeUnited States Food and Drug AdministrationUnited States National Institutes of HealthUniversitiesVaccine ResearchVaccinesconflict resolutiondata managementdata sharingexpectationexperienceinterestmeetingsmembernanoparticlenext generation sequencingprogramsquality assurancesortasevaccine developmentvaccine platform
项目摘要
ABSTRACT- ADMINISTRATIVE CORE
The Administrative Core will coordinate the scientific and administrative activities of this IPCAVD Program,
ensuring that the Projects and Cores function well together. In particular, it will be responsible for managing the
program’s financial management, program management, and coordinating Projects and Cores through scientific
meetings and communications, as well as ensuring full financial and regulatory compliance. A primary activity
of the Core will be monitoring IPCAVD progress relative to milestones and measuring this progress against
available funding to ensure resources are used efficiently. As Specific Aims, the Core will provide overall
IPCAVD management, coordination and supervision of the Program (Aim 1), ensure timely financial accounting
and reporting (Aim 2), ensure compliance with all institutional, state, and federal research and cGMP guidelines
(Aim 3), develop and implement IPCAVD communication, publication, and data sharing plans (Aim 4), and
provide statistical support for all data analyses (Aim 5). The Core will coordinate an annual meeting with an
External Advisory Committee (EAC) that will review the progress of IPCAVD Projects and Cores, and with input
from the DAIDS Program Team, provide guidance for the Program’s direction. Core staff are part of a highly
experienced and integrated management team, which will enable immediate start-up and rapid progress.
This teamwork will accelerate advancement toward the Program’s goals, thus maximizing the opportunities to
positively impact HIV-1 vaccine research in humans.
摘要-行政核心
行政核心将协调IPCAVD计划的科学和行政活动,
确保项目和核心一起运作良好。特别是,它将负责管理
计划的财务管理,计划管理,并通过科学的协调项目和核心
会议和通信,以及确保完全遵守财务和监管规定。一项主要活动
核心小组将监测IPCAVD相对于里程碑的进展情况,并根据
以确保资源得到有效利用。作为具体目标,核心将提供总体
IPCAVD管理、协调和监督项目(目标1),确保及时进行财务核算
和报告(目标2),确保遵守所有机构、州和联邦研究和cGMP指南
(Aim 3)制定和实施IPCAVD的沟通、出版和数据共享计划(目标4),以及
为所有数据分析提供统计支持(目标5)。核心将协调一次年会,
外部咨询委员会(EAC),将审查IPCAVD项目和核心的进展情况,并提供投入
来自DAIDS项目团队,为项目的方向提供指导。核心员工是一个高度
经验丰富的综合管理团队,这将使立即启动和快速进展。
这种团队合作将加速实现该计划的目标,从而最大限度地增加机会,
积极影响人类HIV-1疫苗研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KEVIN O SAUNDERS其他文献
KEVIN O SAUNDERS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KEVIN O SAUNDERS', 18)}}的其他基金
Conjugate nanoparticle platform development for HIV-1 envelope immunogens
HIV-1 包膜免疫原的共轭纳米颗粒平台开发
- 批准号:
10541860 - 财政年份:2021
- 资助金额:
$ 27.69万 - 项目类别:
Project 1. Optimization and in vivo evaluation of HIV-1 Env trimer sortase A-conjugated nanoparticles
项目1. HIV-1 Env三聚体分选酶A结合纳米粒子的优化及体内评价
- 批准号:
10369069 - 财政年份:2021
- 资助金额:
$ 27.69万 - 项目类别:
Conjugate nanoparticle platform development for HIV-1 envelope immunogens
HIV-1 包膜免疫原的共轭纳米颗粒平台开发
- 批准号:
10369067 - 财政年份:2021
- 资助金额:
$ 27.69万 - 项目类别:
Project 1. Optimization and in vivo evaluation of HIV-1 Env trimer sortase A-conjugated nanoparticles
项目1. HIV-1 Env三聚体分选酶A结合纳米粒子的优化及体内评价
- 批准号:
10541863 - 财政年份:2021
- 资助金额:
$ 27.69万 - 项目类别:
HIV-1 vaccine-elicited antibodies target envelope glycans
HIV-1 疫苗引发的抗体靶向包膜聚糖
- 批准号:
10454824 - 财政年份:2015
- 资助金额:
$ 27.69万 - 项目类别:
HIV-1 vaccine-elicited antibodies target envelope glycans
HIV-1 疫苗引发的抗体靶向包膜聚糖
- 批准号:
9089881 - 财政年份:2015
- 资助金额:
$ 27.69万 - 项目类别:
HIV-1 vaccine-elicited antibodies target envelope glycans
HIV-1 疫苗引发的抗体靶向包膜聚糖
- 批准号:
10082482 - 财政年份:2015
- 资助金额:
$ 27.69万 - 项目类别:
HIV-1 vaccine-elicited antibodies target envelope glycans
HIV-1 疫苗引发的抗体靶向包膜聚糖
- 批准号:
10674728 - 财政年份:2015
- 资助金额:
$ 27.69万 - 项目类别:
HIV-1 vaccine-elicited antibodies target envelope glycans
HIV-1 疫苗引发的抗体靶向包膜聚糖
- 批准号:
10219934 - 财政年份:2015
- 资助金额:
$ 27.69万 - 项目类别:
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 27.69万 - 项目类别:
Standard Grant














{{item.name}}会员




